Vericel Corp (VCEL) stock
VCELNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 14/30329% above fair value
$58.65+0.77 (+1.33%)
Close on Nov 18, 2026Market cap $3.00BP/E 139.6Yield –
Vericel pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
Vericel's pe ratio was 141.6× on Nov 11, 2026, against 211.8× a year earlier. Over the last 3 years it ranged from 90.1× to 925.8×, with a median of 256.4×.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 141.6× | −48.0 |
| 2025 | Dec 31, 2025 | 189.5× | −594.9 |
| 2024 | Dec 31, 2024 | 784.4× | +528.8 |
| 2021 | Oct 29, 2021 | 255.7× | – |
See a number that looks wrong?